Retour au classement

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (MURGY)

Sous-évalué
Financial ServicesInsurance - ReinsuranceGermany

Fondamental

77

Prix

$498.80

Capitalisation boursière

$64.49B

Partie 1 · Ce que vaut l'entreprise

Vue d'ensemble

Munich Re takes on risk that other insurers do not want to carry alone. As a reinsurer, it agrees to cover a share of the claims a primary insurer might face from earthquakes, hurricanes, life and health claims and other large exposures, in exchange for a share of the premium. Through its ERGO subsidiary, it also sells insurance policies directly to households and businesses, mainly in Europe and Asia.

Comment l'entreprise gagne de l'argent

Revenue is the premium collected for agreeing to take on risk, whether from another insurer (reinsurance) or directly from a policyholder (ERGO). Profit comes from two sources: an underwriting result, when premiums collected exceed claims paid and expenses, and investment income earned on the funds held between collecting a premium and eventually paying claims. Both depend on pricing risk accurately, which is the core skill of the business.

Chiffre d'affaires par segment

Reinsurance64.1%

Property-casualty, life and health risk assumed from other insurers worldwide; the larger and more volatile of the two businesses.

ERGO (primary insurance)35.9%

Insurance policies sold directly to retail and commercial customers, mainly in Germany and other European and Asian markets.

Avantage concurrentiel

Économies d'échelle · Étroit

Underwriting catastrophe and life risk well requires decades of loss data, capital strong enough to survive a very bad year, and pricing discipline, which keeps the reinsurance market concentrated among a handful of large global players. The advantage is real but not exclusive: Swiss Re, Hannover Re and others compete on the same basis for the same large ceding companies.

Ce qui stimule la demande

Cyclique

Reinsurance pricing moves in multi-year hard and soft cycles driven by recent loss experience rather than by GDP: after a run of large catastrophe losses, prices and terms harden industry-wide, and they soften again once capital rebuilds and competition returns.

Principaux risques

  • Natural catastrophe and climate risk — Insurance risk, mainly property-casualty underwriting risk, makes up around 60% of the group's regulatory capital requirement. Global natural-disaster losses reached about $224 billion in 2025, of which insurers covered roughly $108 billion, and Munich Re carries a direct share of that exposure.
  • Market risk on the investment portfolio — Premiums held between collection and claims payment are invested in bonds and other assets, so swings in interest rates and capital markets affect both investment income and the value of reserves held against future claims.
  • Credit and counterparty risk — The group is exposed to the risk that ceding companies, retrocessionaires or bond issuers in its investment portfolio fail to meet their obligations, one of the risk categories tracked under its Solvency II capital model.

Les arguments en faveur

Buyers argue that rising natural-catastrophe losses are pushing the whole reinsurance market toward firmer pricing and stricter terms, that Munich Re's scale and underwriting discipline let it selectively write the most attractively priced business, and that a fifth straight year of exceeding profit guidance shows the model working through the cycle.

Les arguments contre

Sellers fear that climate change is making catastrophe losses larger and less predictable than historical models assume, that a prolonged period of soft pricing could follow the current hard market as competitors rebuild capital, and that a sharp move in interest rates could hurt the investment portfolio at the same time claims are rising.

Written by the editors, published on 18 août 2026

Direct competitors

Who this company fights with for the same customers

Compare

Generated on 19 septembre 2026 with claude-haiku-4-5 — shared with all users

P/E: 10.8Score: 83Market cap: $16.52B

RGA is the direct rival of Munich Re's life and health reinsurance business, competing for mortality, morbidity and longevity treaties with the same life insurers.

Swiss Re Ltd (Schweizerische Rückversicherungs-Gesellschaft AG)SREN

Swiss Re is the other global full-line reinsurer of Munich Re's size, bidding for the same property-casualty and life reinsurance treaties with the same large primary insurers worldwide.

Hannover Rück SEHNR1

The other large German reinsurer competes with Munich Re on the same European and international treaty renewals, with a leaner cost structure aimed at the same cedants.

SCOR SESCR

The French group is the fourth European composite reinsurer, competing for the same property-casualty and life & health reinsurance programmes in Europe, Asia and the Americas.

Berkshire Hathaway Inc. (National Indemnity / Berkshire Hathaway Reinsurance Group)BRK.B

Berkshire's reinsurance arm writes the same large catastrophe and retroactive covers, and its balance-sheet capacity makes it the preferred alternative on the biggest single placements.

Everest Group, Ltd.EG

The Bermuda-based group competes on the same property-catastrophe and casualty treaty renewals in North America and internationally, alongside its own primary specialty book.

Bilan & Liquidités

Chiffre d'affaires

$63.95B

12 derniers mois (au 30/06/2026)

Résultat net

$6.87B

12 derniers mois (au 30/06/2026)

Flux de trésorerie libre

$6.89B

Capitaux propres totaux

$33.56B

Passif total

$8.22B

Ratio de liquidité général

0.28

Couverture des intérêts

-

Dette/EBITDA

-

Bénéfice par action

Chiffre d'affaires & Résultat net

Flux de trésorerie libre

Décomposition du résultat

État historique

Marges dans le temps

La dette dans le temps

Le poids de la dette

Grille de la croissance

Croissance — Chiffre d'affaires

Estimation de la juste valeur

Cas généralSous-évalué

Juste valeur

$1579.56

Prix actuel

$498.80

Marge de sécurité

+68.4%

Fourchette de juste valeur

$1026.72 - $2132.41

Écart entre les méthodes de valorisation utilisées, pas un intervalle de confiance calibré statistiquement.

Méthodes d'estimation

Objectif de cours des analystes:$549.78
Flux de trésorerie actualisés (DCF):$2735.82
Multiple de résultat (P/E):Données insuffisantes pour le calculer
Formule de croissance de Graham:$2767.05
Valeur de la capacité bénéficiaire (EPV):$780.49
P/B justifié:$1077.63
Actualisation des dividendes (Gordon):$523.87
P/FFO, les fonds provenant de l'exploitation:Données insuffisantes pour le calculer
Bénéfices de milieu de cycle:Données insuffisantes pour le calculer
Multiple sur le chiffre d'affaires:$1318.94
Consensus des analystes:Acheter (14B / 10H / 4S)
Dernière surprise sur les résultats:+20.15%

Indicateurs de valorisation

Ratio P/E

9.53

ROE

21.3%

Ratio P/B

1.92

P/FCF

9.36

Marge brute

35.4%

ROIC

20.2%

Radar de rentabilité

Création de valeur (avantage concurrentiel)

ROIC

20.2%

WACC

7.1%

ROIC − WACC

+13.1 pp

Le ROIC dépasse le coût du capital — l'entreprise crée de la valeur pour les actionnaires.

Critères d'analyse fondamentale

Réussi (15)

  • Price CAGR 11.20%
  • ROIC 20.2%
  • Gross Margin 35.4%
  • P/FCF 9.36
  • P/B Ratio 1.92
  • Debt/Equity ratio
  • Positive Free Cash Flow
  • CapEx intensity
  • DCF valuation (Undervalued)
  • ROE 20.6%
  • Analyst Consensus 50% Buy
  • Earnings Surprise avg 4.9%
  • PEG Ratio 0.23
  • Earnings Quality (OCF/NI) 1.08
  • Net Margin Trend 8.5% vs 7.8%

Échoué (3)

  • Current Ratio
  • Revenue Growth 5Y -0.2%
  • Piotroski F-Score 2/9

Indisponible (9)

  • EPS data insufficient
  • Dividend Payout NaN%
  • Operating Margin NaN%
  • Interest Coverage
  • Debt/EBITDA
  • Return on Tangible Assets
  • Low reliance on intangibles
  • Price below Graham Number
  • Share Dilution (missing shares data)

Score F de Piotroski

2/9

Préoccupations financières sérieuses

score
criteria

Qualité des bénéfices

1.08

Qualité élevée : bénéfices soutenus par la trésorerie

Dilution du capital

-

Rachat d'actions. Favorable aux actionnaires

Participations institutionnelles

Gouvernance

Équipe dirigeante

NomTitreÂge
Dr. Christoph JureckaCEO & Chairman of Management Board51
Dr. Thomas BlunckMember of Management Board60
Dr. Markus RiessHead of Economics, Sustainability & Public Affairs and Member of Management Board59
Ms. Mari-Lizette MalherbeMember of Management Board-
Mr. Nicholas J. Gartside C.F.A.Chief Investment Officer & Member of Management Board50
Dr. Achim KassowChief Transformation Officer & Member of Management Board59
Mr. Stefan Heinrich GollingMember of Management Board & Labour Relations Director48
Ms. Clarisse KopffMember of Management Board-
Mr. Michael KernerMember of Management Board-
Mr. Andrew James BuchananCFO & Member of Management Board46

Risque d'audit

2

Risque du conseil

4

Risque de rémunération

2

Risque droits des actionnaires

1

Partie 2 · Le prix et le moment d'entrer

Cette partie ne dit pas si l'entreprise vaut la peine : elle aide à choisir quand l'acheter, une fois que les fondamentaux vous ont convaincu. À l'intérieur : analyse technique, potentiel, baisses historiques, exposition gamma.

Latest News

Recent headlines for MURGY, sourced from Markets Gazette.

No recent news for MURGY.